These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 16482090

  • 1. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC, Bermúdez-Silva FJ, Malinen H, Hyytiä P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M.
    Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
    [Abstract] [Full Text] [Related]

  • 2. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol.
    Vinod KY, Sanguino E, Yalamanchili R, Manzanares J, Hungund BL.
    J Neurochem; 2008 Jan; 104(1):233-43. PubMed ID: 17944864
    [Abstract] [Full Text] [Related]

  • 3. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 4. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Rubio M, Fernández-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA.
    Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
    [Abstract] [Full Text] [Related]

  • 5. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):11-9. PubMed ID: 17644084
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr 14; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 7. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul 14; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 8. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermúdez-Silva FJ, Navarro M, Ciccocioppo R, de Fonseca FR, European TARGALC Consortium.
    Eur J Neurosci; 2005 Apr 14; 21(8):2243-51. PubMed ID: 15869521
    [Abstract] [Full Text] [Related]

  • 9. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
    Malinen H, Hyytiä P.
    Alcohol Clin Exp Res; 2008 Nov 14; 32(11):1976-83. PubMed ID: 18782338
    [Abstract] [Full Text] [Related]

  • 10. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2006 Nov 14; 189(1):59-69. PubMed ID: 16969683
    [Abstract] [Full Text] [Related]

  • 11. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr 14; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 12. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec 14; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 14; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 14. Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.
    Vinod KY, Maccioni P, Garcia-Gutierrez MS, Femenia T, Xie S, Carai MA, Manzanares J, Cooper TB, Hungund BL, Colombo G.
    Addict Biol; 2012 Jan 14; 17(1):62-75. PubMed ID: 21309960
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C, Markert A, Zimmer A.
    Eur Neuropsychopharmacol; 2015 Aug 14; 25(8):1388-96. PubMed ID: 25910421
    [Abstract] [Full Text] [Related]

  • 16. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias.
    Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A.
    Eur J Neurosci; 2003 Sep 14; 18(6):1607-14. PubMed ID: 14511339
    [Abstract] [Full Text] [Related]

  • 17. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

  • 18. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG.
    Psychopharmacology (Berl); 2008 Oct 24; 200(3):333-46. PubMed ID: 18545985
    [Abstract] [Full Text] [Related]

  • 19. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 24; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 20. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 24; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.